Does government expenditure reduce inequalities in infant mortality rates in low- and middle-income countries?: A time-series, ecological analysis of 48 countries from 1993 to 2013.


Journal

Health economics, policy, and law
ISSN: 1744-134X
Titre abrégé: Health Econ Policy Law
Pays: England
ID NLM: 101247224

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 28 6 2018
medline: 18 12 2019
entrez: 28 6 2018
Statut: ppublish

Résumé

Inequalities in infant mortality rates (IMRs) are rising in some low- and middle-income countries (LMICs) and decreasing in others, but the explanation for these divergent trends is unclear. We investigate whether government expenditures and redistribution are associated with reductions in inequalities in IMRs. We estimated country-level fixed-effects panel regressions for 48 LMICs (142 country observations). Slope and Relative Indices of Inequality in IMRs (SII and RII) were calculated from Demographic and Health Surveys between 1993 and 2013. RII and SII were regressed on government expenditure (total, health and non-health) and redistribution, controlling for gross domestic product (GDP), private health expenditures, a democracy indicator, country fixed effects and time. Mean SII and RII was 39.12 and 0.69, respectively. In multivariate models, a 1 percentage point increase in total government expenditure (% of GDP) was associated with a decrease in SII of -2.468 [95% confidence intervals (CIs): -4.190, -0.746] and RII of -0.026 (95% CIs: -0.048, -0.004). Lower inequalities were associated with higher non-health government expenditure, but not higher government health expenditure. Associations with inequalities were non-significant for GDP, government redistribution, and private health expenditure. Understanding how non-health government expenditure reduces inequalities in IMR, and why health expenditures may not, will accelerate progress towards the Sustainable Development Goals.

Identifiants

pubmed: 29945690
pii: S1744133118000269
doi: 10.1017/S1744133118000269
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

249-273

Auteurs

Peter Baker (P)

1Public Health Consultant and Honorary Clinical Fellow,The Department of Primary Care & Public Health,Imperial College London,London,UK.

Thomas Hone (T)

2Research Fellow,The Department of Primary Care & Public Health,Imperial College London,London,UK.

Aaron Reeves (A)

3Associate Professor, Department of Social Policy and Intervention, University of Oxford, Oxford, UKAssociate Professorial Research Fellow,International Inequalities Institute,London School of Economics and Political Science,London,UK.

Mauricio Avendano (M)

4Reader in Global Ageing,Department of Social Science, Health and Medicine,King's College London,London,UK.

Christopher Millett (C)

5Professor of Public Health,The Department of Primary Care & Public Health,Imperial College London,London,UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH